The presence of dysregulated Nkx 2–5 is present in cancers such as ALL, because there it is working in a very different microenvironment and with different regulatory genes such as Mef2c-Nkx2–5 complex, which plays oncogenic role. The gene discussed is MEF2C; the disease is acute lymphoblastic leukemia.